Welcome to Mundipharma

This website is intended to provide information for Mundipharma’s global business. Please visit our regional websites for access to regional and country specific information.

About Us

As a global network of independent associated companies, we put healthcare professionals and the patients they serve, at the heart of everything we do, advancing affordable treatment options, in areas of high unmet need.

Founded almost 70 years ago, we have a diverse and growing global portfolio of medicines in specialist therapy areas including Analgesia, Anti-fungals, Biosimilars, Diabetes, Oncology, Ophthalmology, Pain, Respiratory, and Consumer Health.

Latest News

Mundipharma ranked one of the 2020 Best Workplaces in Europe by Great Place to Work®

Sep 11 2020

Laboratory Studies Confirm BETADINE® Antiseptic Products’ Effectiveness Against COVID-19 Virus Study published in Infectious Disease and Therapy Journal

Aug 07 2020

Studies Confirm BETADINE’s® Effectiveness Against COVID-19 Virus The antiseptic range of products demonstrated strong virucidal activity, killing the SARS-CoV-2 virus in 30 seconds with a 99.99 percent kill rate.

Aug 06 2020

Over 4,000 employees

Presence in 124 countries

Revenues in excess of $2 billion

Regional websites

For more information please visit our regional websites

“Mundipharma is at an exciting point in its transformational journey. One focussed on creating a culture of innovation and differentiation, where every individual employee counts and can make a real difference.”
Marc Princen, Global CEO